The ARIE Joint Position Paper highlighting how a common, complementary approach by Europe’s analytical RIs will help address the societal challenges of the Horizon Europe Missions framework programme was presented today.
The two large European networks, together representing 28 large-scale analytical research facilities—including Europe’s premier synchrotrons, neutron sources and free-electron lasers—will begin a formal cooperation to advance their common strategic, scientific and technical goals.
“Neutrons for Magnetic Nanostructures on Surfaces: Beyond the Specular Intensity Wars”
PSI instrument scientist Artur Glavic will present a talk highlighting Polarized Neutron Reflectometry and the instrumentation that enables this technique.
The Budapest Neutron Centre (BNC) has organised a new webinar series on the history, science, development and new trends in the field of Li-ion batteries, including the important contributions from neutron scattering techniques all over the world. It starts June 10.
“Viruses: the devils who can take over our cells”
The first LENS webinar highlighted how neutrons address global health threats, and features Université Grenoble-Alpes professor, Marc Jamin, who spoke about viral threats.
The next meeting of the LENS General Assembly and Executive Board will be held by videoconference on the afternoon of Tuesday, 9 June.
An international collaboration between the UK’s UCL School of Pharmacy, LP3 at Lund University, and ESS has initiated bio-physical and structural studies of three non-structural proteins from the novel coronavirus, SARS CoV-2, the causative agent of COVID-19.
Policy piece in the CERN Courier by LENS Chair Helmut Schober highlights the enormous potential for growth in Europe’s world-leading neutron science ecosystem.
To fight Covid-19, a variety of neutron scattering methods will be required to get the full picture of the “invisible enemy” the world has found itself at war with.
As with HIV before it, Europe’s advanced neutron sources will make an essential contribution to the fight against the SARS-CoV-2 virus.